Qiming U.S. Ventures Management as of Sept. 30, 2023
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 7 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Icosavax | 36.1 | $27M | 3.5M | 7.75 | |
| Ventyx Biosciences (VTYX) | 31.6 | $24M | 686k | 34.73 | |
| Talaris Therapeutics | 10.9 | $8.2M | 2.9M | 2.81 | |
| Hillevax (HLVX) | 10.0 | $7.5M | 559k | 13.45 | |
| Jasper Therapeutics | 7.9 | $6.0M | 8.5M | 0.70 | |
| Elevation Oncology (ELEV) | 2.1 | $1.6M | 2.4M | 0.66 | |
| Kezar Life Sciences (KZR) | 1.3 | $986k | 829k | 1.19 |
